Citation Impact
Citing Papers
Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
1976 StandoutNobel
Vitamin C supplements and diabetic cutaneous capillary fragility.
1975
Short and long‐term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome
1991
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
2002 Standout
Methodology in conducting a systematic review of systematic reviews of healthcare interventions
2011 Standout
MEGAVOLTAGE PITUITARY IRRADIATION IN THE MANAGEMENT OF CUSHING'S DISEASE AND NELSON'S SYNDROME: LONG‐TERM FOLLOW‐UP
1989
Treatment of Cushing’s Disease: A Retrospective Clinical Study of the Latest 100 Cases
2006
Cushing's syndrome
2015 Standout
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
A follow up of silastic sling for genuine stress incontinence
1995
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Cerebral circulation during diabetes mellitus
1993
Pentoxifylline
1987 Standout
LONG‐TERM FOLLOW‐UP OF LOW‐DOSE EXTERNAL PITUITARY IRRADIATION FOR CUSHING'S DISEASE
1990
MEDICAL THERAPY FOR CUSHING'S DISEASE
1999
Nutrition and platelet function in atherogenesis
1987
Platelet aggregation, disc haemorrhage and progressive loss of visual fields in glaucoma
1992
The biochemistry and medical significance of the flavonoids
2002 Standout
Neurovascular regulation in the normal brain and in Alzheimer's disease
2004 Standout
Diabetes and Atherosclerosis
2002 Standout
Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders
2001 Standout
Medical Therapy of Cushing's Disease
2002
The incidence of genital prolapse after the Burch colposuspension
1992
Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence
1997 Standout
The impact of ocular blood flow in glaucoma
2002 Standout
Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)
2005 Standout
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Cushing's syndrome
2006 Standout
Systematic review and meta‐analysis of methods of diagnostic assessment for urinary incontinence
2006
COMPLICATIONS OF SILICONE SLING INSERTION FOR STRESS URINARY INCONTINENCE
2000
Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes
1978 StandoutNobel
[Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women].
2001 Standout
Studies on the effects of ββ'-iminodipropionitrile and o-(β-hydroxyethyl)-rutoside on ADP-activated aggregation of rat platelets in relation to the development of diabetic microangiopathy
1975
Maturation of the hemostatic system during childhood
1992 Standout
Effect of intracerebroventricularly administered somatostatin on brain monoamine turnover
1978 StandoutNobel
Potential therapeutic applications of aspirin and other cyclo‐oxygenase inhibitors.
1980
An antiserum to 5,6-dihydro prostacyclin (PGI1) which also binds prostacyclin
1978 StandoutNobel
Effects of all CIS-5, 8,11,14,17 eicosapentaenoic acid and PGH3 on platelet aggregation
1979 StandoutNobel
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
1976 StandoutNobel
Systematic review and evaluation of methods of assessing urinary incontinence
2006
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
1977 StandoutNobel
Effect of Prolactin on the Calcium Binding and/or Transport of Ejaculated and Epididymal Human Spermatozoa
1979
: A selective inhibitor of thromboxane synthetase
1977 StandoutNobel
Synthesis of 6,9α-oxido-11α, 15α-dihydroxyprosta-()5, ()13-dienoic acid, an isomer of PGI2 (vane's PGX)
1977 StandoutNobel
Renal actions of prostacyclin
1978 StandoutNatureNobel
A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
1976 StandoutNobel
Vascular actinos of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog
1978 StandoutNobel
Thyrotropin-Releasing Hormone
1982
Inorganic arsenic: A dangerous enigma for mankind
1992
LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study
2013
The chemical structure of prostaglandin X (prostacyclin)
1976 StandoutNobel
Thyroid Hormone Regulation of Metabolism
2014 Standout
The Hypercoagulable States
1985
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
IS HYPERVISCOSITY A TREATABLE COMPONENT OF DIABETIC MICROCIRCULATORY DISEASE?
1977
The Vanilloid Receptor: A Molecular Gateway to the Pain Pathway
2001 StandoutNobel
Synthesis of 6-keto-PGF1α by ram seminal vesicle microsomes
1977 StandoutNobel
Cushing's syndrome
1985
Somatostatin and thyrotropin releasing hormone: Central effect on sleep and motor system
1976
Cushing’s Syndrome: Therapy Directed at the Adrenal Glands
1994
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
2009 Standout
Aspirin Effects on Mortality and Morbidity in Patients With Diabetes Mellitus
1992
The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S)
1977 StandoutNobel
Late onset post-traumatic hypothalamic hypothermia
1983 StandoutNobel
Prostaglandins and Thromboxanes
1978 StandoutNobel
Prostaglandins, their intermediates and precursors: Cardiovascular actions and regulatory roles in normal and abnormal circulatory systems
1979 StandoutNobel
Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls
1979 StandoutNobel
New aspects of the pathogenesis of atherosclerosis: possible approaches to prevention and treatment
1981
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets
1977 StandoutNobel
Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium
1977 StandoutNobel
Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or platelets
1977 StandoutNobel
Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin
1978 StandoutNobel
A Review of Arsenic Poisoning and its Effects on Human Health
1999 Standout
Biosynthesis of prostacyclin (PGI2) and 12L-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE) by pericardium, pleura, peritoneum and aorta of the rabbit
1979 StandoutNobel
Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid
1977 StandoutNobel
Works of Peter Hunter being referenced
Colposuspension for the Treatment of Female Urinary Incontinence
1989
The Value of Clinical Symptoms in the Diagnosis of Urinary Incontinence in the Female
1987
Experience with Silastic Slings for Female Urinary Incontinence
1989
Cutaneous capillary resistance and retinal haemorrhage in diabetes
1971
Platelet adhesiveness and aggregation in relation to diabetic retinopathy
1971
Myocardial Infarction following Surgical Operations
1968
A Double-Blind Trial of Intravenous Thyrotrophin-Releasing Hormone in the Treatment of Reactive Depression
1975
A DOUBLE-BLIND CROSSOVER SEQUENTIAL TRIAL OF ORAL THYROTROPHIN-RELEASING HORMONE IN DEPRESSION
1974
Silastic slings for female incontinence
1990
Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary
1979
DIABETIC RETINOPATHY AND PROLACTIN
1974